.svg){kind=small}
Aug-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Revival is stocked at 37 licensed dispensaries across New York, with the deepest coverage in Rochester, Buffalo, Jamestown, Niagara Falls, and Syracuse. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In August 2026, Revival’s mix tilted heavily to Concentrates at 81.70% share with a month-over-month decline of 29.11%, while Capsules held 13.56% share with 62.16% year-over-year growth but a 46.90% month-over-month drop; Vapor Pens rounded out 4.75% share with a 16.79% month-over-month decline. Despite brand-level sales up 1,096.21% year over year and average price up 45.83%, the category-level month-over-month contractions across all three formats indicate a volume pullback concentrated in the lead franchise, and a rank of 37 in Concentrates in New York signals mid-pack traction that has not yet converted into month-over-month stability. The pattern implies Revival is leveraged to a single category with high price realization but volatile monthly sell-through, so sustaining growth will require smoothing Concentrates’ month-over-month variance while protecting Capsules’ year-over-year momentum.
Positioning-wise, a 37 rank in New York Concentrates alongside an 81.70% category reliance creates exposure to rank swings if monthly demand softens by another 20–30%, while the 45.83% price lift raises elasticity risk in Vapor Pens where share is just 4.75%. The coexistence of 62.16% year-over-year growth in Capsules with a 46.90% month-over-month decline suggests promotion- or launch-driven spikes rather than steady base demand, and the 29.11% month-over-month decline in Concentrates paired with a brand-level 1,096.21% year-over-year surge implies distribution expansion over the year that has not yet normalized into repeat purchasing. The pattern implies Revival’s positioning is that of a price-elevated Concentrates specialist that must diversify share by 5–10 percentage points into Capsules and Vapor Pens to reduce volatility and defend rank during months of softer category flow.
Competitive Landscape
Revival sits at rank 37 in NY Concentrates in August 2026, sliding 9 positions from rank 28 in May 2026 and 12 positions below its peak rank 25 from June 2026; the lack of a year-over-year rank baseline contrasts with the current gap to the top tier. Competitively, Mfny (Marijuana Farms New York) held rank 1 with a 42.4% year-over-year sales increase while UMAMII advanced from rank 33 to rank 3 on a 3,294.5% sales gain, indicating share consolidation at the top as Revival moved from rank 28 in May 2026 to rank 37 in August 2026. With rank erosion of 9 positions over three months and a 12-position gap from its June 2026 peak, the trajectory implies Revival is ceding relative velocity to faster-advancing competitors and must either regain month-over-month momentum or plan for lower shelf visibility.
Notable Products
Power Plant Live Hash Rosin (1g) set the tone in August 2026 with a 116% month-over-month surge to rank 1, while Strawberries and Cream Live Hash Rosin (1g) climbed 50% at rank 4, indicating demand is concentrating at the top of the concentrates lineup. In contrast, steep declines hit Papaya Bomb Live Hash Rosin (1g) at -58% and Power Plant Cold Cured Live Hash Rosin (1g) at -54%, and CBD/THC 1:1 Charge Tablets 20-Pack (100mg CBD, 100mg THC) fell -67% at rank 10, signaling a sharp pullback in secondary formats. With six of the top ten SKUs in Concentrates and only modest movement in Capsules, Revival’s mix is pivoting toward terpene-forward rosin leaders where volatility is high but category share can be defended through flagship drops.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
